Alzamend Neuro earnings were -$4.3M for the trailing 12 months ending Jan 31, 2025, with N/A growth year over year. The latest ALZN earnings report on Jan 31, 2025 announced Q1 2025 earnings of -$1.0M, down 26.6% from last quarter. For the last reported fiscal year 2024 ending Apr 30, 2024, ALZN reported annual earnings of -$9.9M, with -33.1% growth.
On ALZN's earnings call on Invalid Date, Alzamend Neuro (NASDAQ: ALZN) reported Q4 2024 earnings per share (EPS) of -$0.19, up 94.96% year over year. Total ALZN earnings for the quarter were -$1.04 million. In the same quarter last year, Alzamend Neuro's earnings per share (EPS) was -$3.77.
As of the last Alzamend Neuro earnings report, Alzamend Neuro is currently losing money. Alzamend Neuro's net profit (also called net income) for the twelve months ending Jan 31, 2025 was -$4.23 million, a 65.92% decrease year over year.
What was ALZN's earnings growth in the past year?
As of Alzamend Neuro's earnings date in Invalid Date, Alzamend Neuro's earnings has grown year over year. ALZN earnings in the past year totalled -$4.28 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.